Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in newborn screening.

B Wilcken1

  • 1Western Sydney Genetics Program, The Children's Hospital at Westmead, Westmead, New South Wales, Australia. bridgetw@chw.edu.au

Journal of Inherited Metabolic Disease
|March 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotype and genotype in 101 males with X-linked creatine transporter deficiency.

Journal of medical genetics·2013
Same author

The mild form of menkes disease: a 34 year progress report on the original case.

JIMD reports·2013
Same author

The management of pregnancy in maple syrup urine disease: experience with two patients.

JIMD reports·2013
Same author

Mapping spatial and field dependence of magnetic domain memory by soft X-ray speckle metrology.

Journal of synchrotron radiation·2012
Same author

An improved ultra performance liquid chromatography-tandem mass spectrometry method for the determination of alloisoleucine and branched chain amino acids in dried blood samples.

Annals of clinical biochemistry·2011
Same author

3-Methylglutaconic aciduria type I redefined: a syndrome with late-onset leukoencephalopathy.

Neurology·2010
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

Journal of inherited metabolic disease·2026
See all related articles

Tandem mass spectrometry significantly advances newborn screening for rare metabolic disorders. While effective, more data is needed on outcomes and expanding screening to conditions like lysosomal storage disorders presents ethical challenges.

Area of Science:

  • Biochemistry
  • Medical Diagnostics
  • Public Health

Background:

  • Tandem mass spectrometry (TMS) represents a significant advancement in newborn screening.
  • Current TMS screening focuses on amino acid, organic acid, and fatty acid metabolism disorders.
  • The rarity of some disorders and lack of comprehensive databases hinder full understanding of current screening effectiveness.

Purpose of the Study:

  • To evaluate the impact and potential of tandem mass spectrometry in newborn screening programs.
  • To discuss the challenges and future directions for expanding newborn screening.
  • To highlight the need for outcome assessment and address ethical considerations.

Main Methods:

  • Simultaneous diagnosis of multiple disorders using a single test.

Related Experiment Videos

  • Analysis of amino acid, organic acid, and fatty acid metabolism.
  • Review of current screening performance and limitations.

    • Main Results:

    • TMS demonstrates good assay performance for detecting metabolic disorders.
    • Insufficient data exists on many inborn errors of metabolism due to rarity and follow-up variations.
    • Early diagnosis via screening shows overall advantages in reducing mortality and morbidity.

    Conclusions:

    • Tandem mass spectrometry has revolutionized newborn screening, enabling detection of previously rare disorders.
    • Further research and standardized outcome assessments are crucial for optimizing screening programs.
    • Expanding screening to conditions like lysosomal storage disorders requires careful consideration of ethical implications.